IVANTIS ANNOUNCES RESULTS OF HYDRUS™ INTRACANALICULAR IMPLANT STUDY

IRVINE, Calif. --- Ivantis, a developer of novel intraocular devices designed to treat glaucoma by lowering the intraocular pressure (IOP) in the eye, announced today the 6-month results from its multi-center, international Hydrus I study at the European Society of Cataract and Refractive Surgery Meeting (ESCRS).  The results are being presented by Manfred Tetz, MD (Berlin, Germany), PI and first European surgeon to implant the Hydrus device. Ivantis’ Hydrus™Intracanalicular Implant, roughly the size of an eyelash, is placed through a minimally invasive, microsurgical procedure and is